Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Czechia / NCT07009652
Recruiting Observational

Optimization of Transport and Use of a Mobile ECMO Team in Patients With Sudden Cardiac Arrest in the Moravian-Silesian Region

NCT07009652 · tracked via the Priya Life Science Czechia tracker
Sponsor
University Hospital Ostrava
Phase
Observational
Started
2025-05-01
Last updated
2025-06-06

Condition(s) studied

Cardiac Arrest With Successful ResuscitationCardiac Arrest, Cause Unspecified

Investigational drug(s) / intervention(s)

Extracorporeal cardiopulmonary resuscitation (ECPR)

Extracorporeal cardiopulmonary resuscitation (ECPR): Extracorporeal cardiopulmonary resuscitation (commonly known as ECPR) is a method of cardiopulmonary resuscitation (CPR) that passes the patient's blood through a machine in a process to oxygenate the blood supply.

Study summary

This study evaluates the feasibility of implementing a mobile extracorporeal membrane oxygenation (ECMO) team and optimizing patient transport logistics.

Eligibility

Sex
ALL
Min age
3 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: * out-of-hospital cardiac arrest * indication for ECPR Exclusion Criteria: * death at the scene of the accident * withdrawal of the informed consent

Primary outcome measure(s)

  • Neurological outcome after 30 days (CPC score) — 30 days
    Assessment of the neurological status of patients 30 days after the event using the Cerebral Performance Category (CPC) scale, which measures the extent of neurological impairment: * CPC 1 = good neurological condition * CPC 2 = mild impairment * CPC 3-5 = serious impairment, vegetative state or death The primary endpoint of the study is the proportion of patients with a favourable neurological outcome (CPC 1-2).

Trial sites (2)

FacilityCityRegionStatus
Emergency Medial Services, Moravian-Silesian Region Ostrava Moravian-Silesian Region Recruiting
University Hospital Ostrava Ostrava Moravian-Silesian Region Recruiting

More University Hospital Ostrava trials in Czechia

Prehospital ECPR in Moravia Silesia Region Recruiting
On Scene ECPR in Ostrava Recruiting
Evaluation of the Relation Between Patient Fasting Time and the Occurrence of PIH (Post Induction Hypotension) Recruiting
Neoadjuvant Stereotactic Radiotherapy for Brain Metastasis Recruiting
Rectal Cancer CTC Trial Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07009652 on ClinicalTrials.gov ↗ ← All trials in Czechia